指南与共识浆细胞疾病

多发性骨髓瘤疫苗接种建议:欧洲骨髓瘤网络共识

Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network.
指南 / 共识 · Leukemia · 2020-08-19

欧洲骨髓瘤网络发布多发性骨髓瘤患者疫苗接种共识,指出患者因疾病本身及治疗导致的免疫抑制而感染风险增高,应利用所有适当措施激发对流感、肺炎球菌、水痘带状疱疹病毒及流感嗜血杆菌、脑膜炎球菌、肝炎等病原体的有效免疫应答;自体尤其异基因移植后抗体滴度严重降低,需更广泛接种;骨髓瘤患者接种反应常弱于一般人群,需检测接种后抗体滴度或重复接种。

要点

  • 多发性骨髓瘤患者感染风险增高,应利用所有适当措施激发对常见病原体的有效免疫应答。
  • 自体尤其异基因移植后抗体滴度严重降低,需更广泛的疫苗接种。
  • 骨髓瘤患者接种反应常弱于一般人群,需检测接种后抗体滴度或重复接种。

核心结论

  • 应利用所有适当措施激发多发性骨髓瘤患者对流感、肺炎球菌、水痘带状疱疹病毒及流感嗜血杆菌、脑膜炎球菌、肝炎等常见病原体的有效免疫应答。
  • 自体尤其异基因移植后抗体滴度严重降低,需更广泛的疫苗接种。
  • 骨髓瘤患者接种反应常弱于一般人群,需检测接种后抗体滴度或重复接种。

研究设计与样本

  • 欧洲骨髓瘤网络(European Myeloma Network)制定的共识,汇总现有骨髓瘤疫苗接种数据并提供临床实践建议。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vaccination is one of the most successful medical interventions that has saved the life of millions of people. Vaccination is particularly important in patients with multiple myeloma, who have an increased risk of infections due to the disease-inherent immune suppression, and because of the immune suppressive effects of therapy. Hence, all appropriate measures should be exploited, to elicit an effective immune response to common pathogens like influenza, pneumococci, varicella zoster virus, and to those bacteria and viruses (haemophilus influenzae, meningococci, and hepatitis) that frequently may pose a significant risk to patients with multiple myeloma. Patients after autologous, and specifically after allogeneic transplantation have severely reduced antibody titers, and therefore require a broader spectrum of vaccinations. Response to vaccination in myeloma often is less vigorous than in the general population, mandating either measurement of the postvaccination antibody titers and/or repeating the vaccination. Here, we compile the existing data on vaccination in multiple myeloma and provide recommendations for clinical practice.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Ludwig H, Boccadoro M, Moreau P, et al. Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network. Leukemia. 2020. PMID: 32814840. doi:10.1038/s41375-020-01016-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。